Use fundamental data analysis to confirm all available indicators of Vascular Solutions to find out if markets are presently mispricing the corporation. We found thirty available drivers for Vascular Solutions which can be compared to its competition. To make sure the equity is not overpriced, please validate all Vascular Solutions fundamentals including its Debt to Equity, and the relationship between Net Income and Number of Employees . Given that Vascular Solutions has Number of Shares Shorted of 982.09 K, we advise you double-check Vascular Solutions current market performance to make sure the company can sustain itself down the road.Use Vascular Solutions to protect against small markets fluctuations. The stock experiences normal downward trend, but the immediate impact on correlations cannot be determined at the moment . Check odds of Vascular Solutions to be traded at $55.44 in 30 days
Vascular Solutions Valuation Over Time
Vascular Solutions Company SummaryVascular Solutions competes with Edwards Lifesciences, EndoChoice Holdings, Digirad, and LABSTYLE. Vascular Solutions, Inc., a medical device company, offer clinical solutions for treating coronary and peripheral vascular disease worldwide.
Vascular Solutions Cash per Share vs Retained Earnings
Vascular Solutions is rated third in cash per share category among related companies. It is rated second in retained earnings category among related companies reporting about 12,122,422 of Retained Earnings per Cash per Share.